Robinson Chandler bought MNPR
March 31, 2026 · Form 4 insider transaction
Robinson Chandler bought 6,732 shares of Monopar Therapeutics Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,732
Price
N/A
Total value
N/A
InsiderRobinson Chandler
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after92,450
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares acquired on vesting and settlement of restricted stock units.